הלוואות ואשראי לטווח ארוך של החברה: Fractyl (GUTS)
Fractyl Health, Inc. (GUTS) restores natural metabolism by eliminating the root causes of diabetes through tissue regeneration. This US developer leverages advanced obesity treatment methods and support from specialized investors. Current price action on GURU.Markets is 0.00, while the business focuses on identifying strategic partners for the subsequent licensing of its platform following the completion of clinical trials.
פילוחי נתונים אנליטיים מרוכזים עבור Fractyl (GUTS)
The 0.00 metric is formed by aggregating all liabilities with a maturity of more than one year, reflecting the business's dependence on external financing. Amid competition from GLP-1 drugs and clinical trial risks, analyzing the long-term debt of Fractyl Health, Inc. (GUTS) allows for an assessment of the company's financial resilience to develop invasive diabetes treatments without critical pressure from creditors.